ADWYA stock represents Tunisia's pharmaceutical sector

Published on 09/30/2026 at 22:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ADWYA stock represents a Tunisian pharmaceutical business linked to Kilani Group, whose leadership structure dates to 2019. Its website lists products, expertise and partner services.

ADWYA, TN0005700015, Illustration mit AI erstellt.

ADWYA stock (ISIN TN0005700015) represents a Tunisian pharmaceutical manufacturer linked to Kilani Group's healthcare platform. The company operates across products, pharmaceutical expertise and partner services, according to its corporate website.

ADWYA sits within Kilani Group

La Presse de Tunisie reported on September 15, 2026, that Sara Masmoudi has led Kilani Group since 2019 and chairs ADWYA, alongside responsibilities at Teriak and STA. That structure places ADWYA inside a wider Tunisian healthcare network rather than presenting it as an isolated pharmaceutical operation.

The leadership timeline is a concrete marker for investors assessing the company's strategic setting. Since 2019, Masmoudi's role has connected ADWYA with the group's pharmaceutical, healthcare, food and distribution activities, according to the same report.

Tunisian pharma remains the core link

Germany Trade and Invest listed Adwya among Tunisia's established pharmaceutical producers in a report updated September 23, 2026. The company is therefore positioned within a recognized local manufacturing base that also includes Medis, Saiph, Unimed and Teriak.

Entreprises Magazine reported on September 21, 2026, that Kilani Group ranked first in a Tunisian pharmaceutical market ranking with TND 227.9 million in market revenue. The figure belongs to the group context, not specifically to ADWYA, but it shows the scale of the platform surrounding the company.

Corporate profile remains the key marker

ADWYA's own website organizes its operating profile around products, expertise, human resources, pharmacovigilance and partnership services. Those categories point to a manufacturer with both commercial and compliance functions, while the group's 2019 leadership timeline supplies a clear reference for its corporate structure.